Gilead Sciences Added to the Dow Jones Sustainability World Index

Nov 30, 2021 8:55 AM ET

Campaign: Corporate Social Responsibility

We’re proud to be added to the Dow Jones Sustainability World Index, part of S&P Global Dow Jones Indices, based on our performance on the Corporate Sustainability Assessment. The assessment reflects our ongoing commitment to be a leader in this area as we work to discover, develop and deliver innovative therapeutics for people with life-threatening diseases.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Here's a link to the Dow Jones news release.

Gilead Sciences Added to the Dow Jones Sustainability World Index

More from Gilead Sciences

Gilead Foundation’s Healthcare Education, Access and Leadership (HEAL) Initiative Is Dedicating $5 Million to Help Build a More Diverse Bay Area Healthcare Workforce

Gilead Oncology Grant Supports 22 U.S. Organizations With $3.15 Million to Provide Support to Those Affected By Breast Cancer

Gilead Sciences: New Report Shows Every Country in the World Must Do More To End the HIV Epidemic

Championing HIV Services for LGBTQ+ Youth

Working to Build Next-Generation Cancer Therapies

Helping End HIV - Gilead Sciences

Seramount Ranks Gilead Sciences Among Its Leading Inclusion Index Company

Gilead Sciences: Living With a Rare Liver Disease: Maria’s Journey